Case Control Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Feb 21, 2015; 21(7): 2073-2079
Published online Feb 21, 2015. doi: 10.3748/wjg.v21.i7.2073
Table 3 Seroconversions to anti hepatitis B e and anti-hepatitis B surface in both groups n (%)
SeroconversionsGroups
P value
Group 1Group 2
Treatment induced1
HBeAg to HBeAb1 (6.6)9 (53)0.006
Treatment induced
HBsAg to HBsAb00
Total HBeAg to HBeAb10.002
(treatment induced and spontan seroconversion)3 (12.5)15 (60)
Total HBsAg to HBsAb11.000
(treatment induced and spontan seroconversion)1 (4.1)1 (4)